CDH1 and neoplasm: No significant correlation was found between the mutant ERBB2 status and other classical clinicopathological parameters such as age, Elston-Ellis tumor grade, mitotic index, presence of lymphovascular invasion, macroscopic tumor size, lymph node status, ER, PR and E-cadherin expression.